Conmed (CNMD) Misses Q1 EPS by 21c, provides guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $32.54 --0%
EPS Growth %: -3.5%
Financial Fact:
Net Income Basic: 0.26
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -3.5%
Financial Fact:
Net Income Basic: 0.26
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.79, $0.21 worse than the analyst estimate of $1.00. Revenue for the quarter came in at $321.3 million versus the consensus estimate of $332.91 million.
GUIDANCE:
Conmed sees FY2025 EPS of $4.45-$4.60, versus the consensus of $4.34. Conmed sees FY2025 revenue of $1.35-1.378 billion, versus the consensus of $1.357 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Canaccord Reiterates Buy Rating on Achieve Life Sciences (ACHV)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
